Document 0088 DOCN M9440088 TI Viral resistance to the thiazolo-iso-indolinones, a new class of nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase. DT 9404 AU Maass G; Immendoerfer U; Koenig B; Leser U; Mueller B; Goody R; Pfaff E; Bundesforschungsanstalt fur Viruskrankheiten der Tiere,; Tubingen, Germany. SO Antimicrob Agents Chemother. 1993 Dec;37(12):2612-7. Unique Identifier : AIDSLINE MED/94153035 AB Thiazolo-iso-indolinone derivatives with high specificity toward the reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) were identified. The most potent compound, BM +51.0836, inhibited HIV-1 RT at a 50% inhibitory concentration of 90 nM in vitro. In cell culture assays, similar 50% inhibitory concentrations were obtained with high specificity for HIV-1. These substances were equally active against a zidovudine-resistant isolate. No antiviral effect was observed with an HIV-2 isolate. HIV-1 isolates resistant to the thiazolo-iso-indolinones were generated in cell culture, and the nucleotide sequences of the respective RT genes were analyzed subsequently. Comparison of the deduced amino acid sequences with the wild-type sequence showed an amino acid change at position 181 (Tyr to Cys). Substitutions of amino acid Lys-101 and Lys-103 as well as Tyr-181 and/or Tyr-188 by site-directed mutagenesis led to resistance against the thiazolo-iso-indolinones. A chimeric HIV-2 RT, substituted with amino acids at positions 179 to 190 from HIV-1, acquired only partial susceptibility to BM +51.0836. DE Antiviral Agents/*PHARMACOLOGY Base Sequence Cells, Cultured Chimeric Proteins/GENETICS Drug Resistance, Microbial Enzyme-Linked Immunosorbent Assay Human HIV-1/DRUG EFFECTS/ENZYMOLOGY/PHYSIOLOGY Indoles/*PHARMACOLOGY Molecular Sequence Data Mutation/GENETICS Reverse Transcriptase/*ANTAGONISTS & INHIB/GENETICS Thiazoles/*PHARMACOLOGY Virus Replication/DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).